longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

maccura

300463

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -152.30, below the reasonable range, cheaper than 92.83% of the time in the past 5 years, and the industry ranks 27/27, the industry Median 47.85.

-152.3xP/E
¥8.97Stock price
¥-0.06Earnings per share
-152.3xP/E
Stock price¥8.97Earnings per share¥-0.06

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
16.40x
Typical range
-57.65x–24.29x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 47.85x
0125250375500

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 47.85x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688114SHMGI
-107.05x90.39%¥22.63B
688202SHMedicilon
-116.16x--¥12.00B
688068SHHotgen
-30.39x--¥7.88B
603108SHRunda Medical
-10.92x137.36%¥5.63B
300463SZmaccura
-152.30x369.81%¥5.42B
301096SZBio-S
-57.15x--¥5.25B
688238SHOBiO Tech
-17.30x18.92%¥4.01B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.